Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Kidney international. Supplement

• Publication date

  1997-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 9285896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abnormal growth hormone response to ingestion of glucose in juvenile diabetics.

  2009cited by this paper
• Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats

  2004cited by this paper
• Renal hypertrophy in hyperglycemic non-obese diabetic mice is associated with persistent renal accumulation of insulin-like growth factor I.

  1997cited by this paper
• Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats.

  1997cited by this paper
• Streptozotocin induction of diabetes in rats leads to increased insulin-like growth factor-II/mannose-6-phosphate receptor mRNA expression in kidney but not in lung or heart.

  1996cited by this paper
• Effect of lanreotide on local kidney IGF-I and renal growth in experimental diabetes in the rat.

  1996cited by this paper
• A growth hormone antagonist protects mice against streptozotocin induced glomerulosclerosis even in the presence of elevated levels of glucose and glycated hemoglobin.

  1996cited by this paper
• Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention.

  1995cited by this paper
• The role of growth hormone, insulin-like growth factors (IGFs), and IGF-binding proteins in experimental diabetic kidney disease.

  1995cited by this paper
• Insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the kidney of the chronically hypoinsulinemic rat and hyperinsulinemic rat.

  1995cited by this paper
• Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice.

  1995cited by this paper
• Stimulation of hepatic insulin-like growth factor-binding protein-1 and -3 gene expression by octreotide in rats.

  1995cited by this paper
• Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes.

  1995cited by this paper
• Increased kidney and liver insulin-like growth factor II/mannose-6-phosphate receptor concentration in experimental diabetes in rats.

  1994cited by this paper
• IGF-II/Man-6-P receptors in rat kidney: apical localization in proximal tubule cells.

  1993cited by this paper
• Normalization of decreased plasma concentrations of growth hormone-binding protein by insulin treatment in spontaneously diabetic BB rats.

  1993cited by this paper
• The growth hormone insulin-like growth factor axis in kidney revisited

  1993cited by this paper
• Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion.

  1992cited by this paper
• Renal growth hormone receptor gene expression: relationship to renal insulin-like growth factor system.

  1992cited by this paper
• Focal Induction of IGF Binding Proteins in Proximal Tubules of Diabetic Rat Kidney

  1992cited by this paper
• Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats.

  1992cited by this paper
• Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats

  1992cited by this paper
• Insulin-like growth factor system gene expression in the human kidney.

  1992cited by this paper
• Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule.

  1991cited by this paper
• Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human.

  1991cited by this paper
• Kidney insulin-like growth factor-I mRNA levels are increased in postpubertal diabetic rats.

  1991cited by this paper
• Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice.

  1991cited by this paper
• Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat

  1991cited by this paper
• Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats.

  1991cited by this paper
• Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes.

  1991cited by this paper
• Does the serum binding protein for growth hormone have a functional role?

  1991cited by this paper
• Mutations in the third alpha-helix of bovine growth hormone dramatically affect its intracellular distribution in vitro and growth enhancement in transgenic mice.

  1991cited by this paper
• Experimental Diabetes Increases Insulinlike Growth Factor I and II Receptor Concentration and Gene Expression in Kidney

  1990cited by this paper
• Effect of long-acting somatostatin analog (SMS 201-995) on high glomerular filtration rate in insulin dependent diabetic patients.

  1990cited by this paper
• Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice.

  1990cited by this paper
• Expression of the growth hormone-binding protein messenger RNA in the liver and extrahepatic tissues in the rat: co-expression with the growth hormone receptor.

  1990cited by this paper
• Effect of Puberty on Initial Kidney Growth and Rise in Kidney IGF-I in Diabetic Rats

  1990cited by this paper
• Acute Effects of a Somatostatin Analogue on Kidney Function in Type 1 Diabetic Patients

  1990cited by this paper
• Pubertal development and testicular function in the male growth hormone-deficient rat.

  1990cited by this paper
• Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats

  1990cited by this paper
• Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human.

  1990cited by this paper
• Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: relation to severity of diabetes.

  1990cited by this paper
• The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor.

  1989cited by this paper
• Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues.

  1989cited by this paper
• Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats

  1989cited by this paper
• Regulation of rat growth hormone receptor gene expression.

  1989cited by this paper
• Focal expression of insulin-like growth factor I in rat kidney collecting duct

  1988cited by this paper
• Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.

  1988cited by this paper
• The effect of a somatostatin analogue (SMS 201-995, Sandostatin) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in the early renal hypertrophy of experimental diabetes in the rat.

  1988cited by this paper
• Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomised rats

  1988cited by this paper
• Distinct receptors for insulin-like growth factor I in rat renal glomeruli and tubules.

  1988cited by this paper
• Growth hormone-deficient dwarfism in the rat: a new mutation.

  1988cited by this paper
• Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat.

  1987cited by this paper
• Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects.

  1987cited by this paper
• Insulin, IGF-I and growth in diabetic rats

  1987cited by this paper
• Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.

  1987cited by this paper
• Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media.

  1986cited by this paper
• Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.

  1984cited by this paper
• Predicting diabetic nephropathy in insulin-dependent patients.

  1984cited by this paper
• Low Plasma Somatomedin-C in Streptozotocin-induced Diabetes Mellitus: Correlation with Changes in Somatogenic and Lactogenic Liver Binding Sites

  1983cited by this paper
• Renal hypertrophy in experimental diabetes mellitus.

  1983cited by this paper
• Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus.

  1982cited by this paper
• Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin.

  1981cited by this paper
• Renal hypertrophy in experimental diabetes

  1980cited by this paper
• Urinary excretion of albumin and total protein in normal and streptozotocin diabetic rats.

  1980cited by this paper
• Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment

  1979cited by this paper
• Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment

  1979cited by this paper
• Renal hypertrophy in experimental diabetes: A comparison to compensatory hypertrophy

  1978cited by this paper
• Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications.

  1978cited by this paper
• Renal hypertrophy in experimental diabetes: Relation to severity of diabetes

  1977cited by this paper
• Renal hypertrophy in streptozotocin-diabetic rats.

  1976cited by this paper
• Glomerular size and structure in diabetes mellitus. I. Early abnormalities.

  1975cited by this paper
• Increased Kidney Size and Glomerular Filtration Rate in Early Juvenile Diabetes

  1973cited by this paper
• Effect of streptozotocin-induced diabetes on kidney weight and compensatory hypertrophy in the rat.

  1971cited by this paper
• Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics

  1970cited by this paper
• Kidney lesions in rats with severe long term alloxan diabetes. 3. Glomerular ultrastructure.

  1967cited by this paper
• Kidney lesions in rats with severe long-term alloxan diabetes. 2. Histochemical studies, comparison with human diabetic glomerular lesions.

  1966cited by this paper
• Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood.

  1959cited by this paper

• Integrated bioinformatics analysis and in vivo validation of potential immune-related genes linked to diabetic nephropathy

  2024cites this paper
• Protein folding, misfolding and aggregation: A tale of constructive to destructive assembly.

  2018cites this paper
• Insulin Prevents Hyperfiltration and Proteinuria but Not Glomerular Hypertrophy and Increases Mesangial Matrix Expansion in Diabetic Rats

  2016cites this paper
• The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35)

  2015cites this paper
• The Investigation of the Effects of Enalapril and Losartan on Ghrelin Immunoreactivity in Kidney of Streptozotocin-Induced Diabetic Rats

  2013cites this paper
• The primary glomerulonephritides: a systems biology approach

  2013cites this paper
• Effects of long‐term experimental diabetes on adrenal gland growth and phosphoribosyl pyrophosphate formation in growth hormone‐deficient dwarf rats

  2012cites this paper
• Effects of long‐acting somatostatin analogues on adrenal growth and phosphoribosyl pyrophosphate formation in experimental diabetes

  2012cites this paper
• IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cells.

  2012cites this paper
• Expression of biologically active human insulin‐like growth factor 1 in Arabidopsis thaliana seeds via oleosin fusion technology

  2011cites this paper
• IGF-1 increases the expression of fibronectin by Nox 4-dependent Akt phosphorylation 1 in renal tubular epithelial cells

  2011cites this paper
• The effects of type 1 IGF receptor inhibition in a mouse model of diabetic kidney disease.

  2011cites this paper
• The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy.

  2011cites this paper
• Insulin-like growth factor binding protein-1 levels are increased in patients with IgA nephropathy.

  2010cites this paper
• Determination of Ghrelin Immunoreactivity in Kidney Tissues of Diabetic Rats

  2009cites this paper
• Fluvastatin attenuates IGF-1-induced ERK1/2 activation and cell proliferation by mevalonic acid depletion in human mesangial cells.

  2009cites this paper
• Differential effects on kidney and liver growth of a non-viral hGH-expression vector in hypophysectomized mice.

  2007cites this paper
• Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells: effect of the anti‐oxidant α‐lipoic acid

  2007cites this paper
• An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetes.

  2007cites this paper
• Inhibition of the renin-angiotensin system in normotensive type 2 diabetes: effects and mechanisms of action

  2007influential citation
• Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats.

  2007cites this paper
• Compensatory Kidney Growth in Estrogen Receptor α Null Mice Running Title: Compensatory Kidney Growth in αERKO Mice

  2006cites this paper
• An insulin-like growth factor-I gene polymorphism modifies the risk of microalbuminuria in subjects with an abnormal glucose tolerance.

  2006cites this paper
• The IGF‐I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial

  2006cites this paper
• IGF‐1 increases laminin, cyclin D1, and P21Cip1 expression in glomerular mesangial cells: An investigation of the intracellular signaling pathway and cell‐cycle progression

  2006cites this paper
• Proteomic Identification of 14-3-3ζ as an Adapter for IGF-1 and Akt/GSK-3β Signaling and Survival of Renal Mesangial Cells

  2006cites this paper
• An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy.

  2006cites this paper
• Kidney Growth in Normal and Diabetic Mice is not Affected by Human Insulin-Like Growth Factor Binding Protein-1 Administration

  2005cites this paper
• Puberty and chronic kidney disease.

  2005cites this paper
• Emerging drugs for diabetic nephropathy

  2005cites this paper
• Comparison between somatostatin analogues and ACE inhibitor in the NOD mouse model of diabetic kidney disease.

  2004cites this paper
• Potential Adjunctive Therapies in Adolescents with Type 1 Diabetes Mellitus

  2004cites this paper
• From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.

  2004cites this paper
• The physiological and pathophysiological roles of the GH/IGF-axis in the kidney: lessons from experimental rodent models.

  2004cites this paper
• Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis.

  2004cites this paper
• SERUMSKE VREDNOSTI SOMATOSTATINA U TIPU 2 DIABETES MELLITUSA

  2004cites this paper
• The GH/IGF axis in the mouse kidney

  2004cites this paper
• Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathy.

  2003cites this paper
• Growth Hormone (GH) Hypersecretion and GH Receptor Resistance in Streptozotocin Diabetic Mice in Response to a GH Secretagogue

  2003cites this paper
• Regulation of growth-hormone-receptor gene expression by growth hormone and pegvisomant in human mesangial cells.

  2003cites this paper
• IGF-I induces vascular endothelial growth factor in human mesangial cells via a Src-dependent mechanism.

  2003cites this paper
• IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose.

  2003cites this paper
• Reversion of ‘Early Worsening’ of Diabetic Retinopathy by Deliberate Restoration of Poor Metabolic Control

  2003cites this paper
• Growth hormone disturbances in adolescents with type 1 (insulin-dependent) diabetes mellitus : differentiating the GH signal

  2002cites this paper
• IGF-binding protein-5: flexible player in the IGF system and effector on its own.

  2002cites this paper
• Effect of Mild Hypoinsulinemia on Renal Hypertrophy: Growth Hormone/Insulin-Like Growth Factor I System in Mild Streptozotocin Diabetes

  2002influential citation
• Diabetic kidney disease: impact of puberty.

  2002cites this paper
• Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation.

  2002cites this paper
• Modulation of growth hormone signal transduction in kidneys of streptozotocin-induced diabetic animals: effect of a growth hormone receptor antagonist.

  2002cites this paper
• Therapeutic Potential of Insulin-Like Growth Factor-1 in Patients with Diabetes Mellitus

  2002cites this paper
• OCTREOTIDENİN YENİDOĞAN STREPTOZOTOCIN DİYABETİK SIÇAN BÖBREĞİ VE IGF-1 DÜZEYLERİ ÜZERİNE ETKİLERİ

  2002cites this paper
• Inhibition of IGF-I-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin.

  2002cites this paper
• Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice.

  2002influential citation
• Comparative endocrinology of the insulin-like growth factor-binding protein.

  2002cites this paper
• Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat.

  2001cites this paper
• Puberty permits increased expression of renal transforming growth factor-β1 in experimental diabetes

  2001cites this paper
• Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney.

  2001cites this paper
• A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.

  2001cites this paper
• Potential use of growth hormone receptor antagonist in the treatment of diabetic kidney disease.

  2001cites this paper
• Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.

  2001cites this paper
• The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure.

  2001cites this paper
• Sex differences in the renal transforming growth factor-β1 system after puberty

  2001cites this paper
• Activation of renal signaling pathways in db/db mice with type 2 diabetes.

  2001cites this paper
• Translational regulation of renal proximal tubular epithelial cell transforming growth factor-beta1 generation by insulin.

  2001cites this paper
• Somatostatin Analogue Attenuates Estrogen-Induced Augmentation of Glomerular Injury in Spontaneous Hypercholesterolemic Female Imai Rats

  2001cites this paper
• Effects of IGFBP-2 overexpression in vitro and in vivo

  2000cites this paper
• Protection against Diabetes-Induced Nephropathy in Growth Hormone Receptor/Binding Protein Gene-Disrupted Mice1.

  2000cites this paper
• The Renal Expression of Transforming Growth Factor-β Isoforms and Their Receptors in Acute and Chronic Experimental Diabetes in Rats.

  2000cites this paper
• The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats.

  2000cites this paper
• Octreotide administration in diabetic rats: effects on renal function and morphology.

  2000cites this paper
• Transgenic mouse models for studying the functions of insulin‐like growth factor‐binding proteins

  2000cites this paper
• Protection against diabetes-induced nephropathy in growth hormone receptor/binding protein gene-disrupted mice.

  2000cites this paper
• An Update on the Role of Growth Factors in the Development of Diabetic Kidney Disease

  2000cites this paper
• Cell cycle regulation in diabetic nephropathy.

  2000cites this paper
• IGF-I treatment attenuates renal abnormalities induced by neonatal ACE inhibition.

  2000cites this paper
• Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1.

  2000cites this paper
• Alterations of the Rat Mesentery Vasculature in Experimental Diabetes

  2000cites this paper
• Insulin-like growth factor binding proteins (IGFBPs) in serum and urine and IGFBP-2 protease activity in patients with insulin-dependent diabetes mellitus.

  2000cites this paper
• Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent.

  1999cites this paper
• Growth hormone receptor antagonism prevents early renal changes in nonobese diabetic mice.

  1999cites this paper
• Pathophysiological Role of Growth Factors in Diabetic Kidney Disease: Focus on Innovative Therapy.

  1999cites this paper
• Alterations in the Growth Hormone-Insulin-Like Growth Factor Axis in Insulin Dependent Diabetes Mellitus

  1999cites this paper
• The Role of Growth Hormone, Insulin-Like Growth Factors, Epidermal Growth Factor and Transforming Growth Factor β in Diabetic Kidney Disease: An Update

  1998cites this paper
• The kidney and hypertension in diabetes mellitus

  1989cites this paper
• Transgenic Mouse Models for Studying the Functions of Insulin-like Growth Factor-binding Proteins Transgenic Mouse Models for Studying the Functions of Insulin-like Growth Factor-binding Proteins. Faseb

  year unknowncites this paper